A new drug being trialled for treating breast cancer and diabetes has been shown to ‘melt away’ the fat inside arteries that can cause heart attacks and strokes.
Researchers from the University of Aberdeen, using pre-clinical mouse models, showed that just a single dose of the drug (Trodusquemine) completely reversed the effects of a disease that causes a host of heart problems.
Atherosclerosis is the build-up of fatty material inside the arteries.
Over time this fatty material can grow bigger until your arteries become so narrow that not enough blood can pass through.
Atherosclerosis is the condition that causes most heart attacks and strokes.
In pre-clinical tests, mice with set-in atherosclerosis, mimicking what happens in humans, had less fatty plaques in their arteries whether they had regular doses over time or just a single dose of Trodusquemine.
The drug works by stopping an enzyme called PTP1B, which is normally increased in people with obesity or diabetes and conditions involving prolonged inflammation such as sepsis, inflamed diabetic foot ulcers and allergic lung inflammation. The researchers found that it also stimulated the action of another protein (AMPK), which effectively mimics exercise and reduces chronic inflammation.
It has already been shown to be effective with diabetes and breast cancer patients but this is the first time the drug has been shown to have benefits for long-term cardiovascular disease.
The £236,000 study was funded by the British Heart Foundation.
Professor Mirela Delibegovic and Dr Dawn Thompson from the University of Aberdeen’s Institute of Medical Sciences who led the study said: “All humans have some level of atherosclerosis. As you age you start to develop these fatty streaks inside your arteries. It is a big problem for people who are overweight or have underlying cardiovascular conditions.”
“Trodusquemine has already been trialled for treatment of diabetes and breast cancer but this is the first time it has been used in models of atherosclerosis.
“These have only been tested at pre-clinical level, in mice, so far but the results were quite impressive and showed that just a single dose of this drug seemed to completely reverse the effects of arthrosclerosis.
“The next step is to test the ability of this drug to improve outcomes in human patients with developed atherosclerosis and cardiovascular disease”.
Learn more: Drug ‘melts away’ fat inside arteries
The Latest on: Atherosclerosis
- Nikolai N. Anichkov and His Theory of Atherosclerosison October 8, 2021 at 9:35 pm
Nikolai N. Anichkov (1885–1964) first demonstrated the role of cholesterol in the development of atherosclerosis. His classic experiments in 1913 paved the way to our current understanding of the role ...
- Prevalence of Noncalcified Coronary Plaques and CAC in People Living With HIVon October 8, 2021 at 7:25 am
People living with HIV had a higher prevalence of noncalcified coronary plaques compared with HIV-negative individuals. Coronary artery calcification (CAC) prevalence, however, was similar between ...
- Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.on October 6, 2021 at 12:07 pm
In this study, we questioned whether in vivo probucol could prevent the progression of atherosclerosis in homozygous Watanabe heritable hyperlipidemic (WHHL) rabbits, an animal model for familial ...
- Study: Nearly half of middle-aged adults have fatty buildup in arterieson September 29, 2021 at 9:15 pm
A new study in the scientific journal Circulation shows many middle-aged adults with no history of heart trouble already have fatty deposits built up in their arteries.
- Coronary CT Angiography may detect 'silent' atherosclerosis: Studyon September 29, 2021 at 9:15 pm
Detection of 'silent' coronary atherosclerosis is possible using coronary computed tomography angiography, suggests a study published in the Circulation. Early detection of ...
- Does Exercise Accelerate Atherosclerosis?on September 29, 2021 at 5:39 am
The last thing anyone expects an athlete to die of is a heart attack. It happened to Jim Fixx, running aficionado and best-selling author of The Complete B | Health And Medicine ...
- Developing new class of drugs based on targeting of mechanical pathways can be a game changer for CVDson September 29, 2021 at 2:40 am
Professor Paul Evans, Professor of Cardiovascular Science, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, UK explains Express Healthcare about his award-winning ...
- Silent Coronary Atherosclerosis Prevalent on CT in Middle Ageon September 28, 2021 at 2:50 pm
CT angiography also detected atherosclerosis in cases missed by coronary artery calcium testing in a population-based cohort without known heart disease.
- Subclinical Atherosclerosis Common in General Population, Even Those With Zero CACon September 24, 2021 at 1:34 pm
The study is the first population-based sample to confirm that having no calcium does not mean no disease, one expert notes.
- Atherosclerosis present in 42% of adults without heart diseaseon September 22, 2021 at 7:59 am
A study conducted in Sweden found that about 42% of the participants without known heart disease or symptoms had fatty deposits in the arteries of their heart, which experts call atherosclerosis.
via Google News and Bing News